NSE filing, NSE: FINKURVE. Summary written from the filing by ALFA Finder's alert engine.
Finkurve Financial Services Ltd: key numbers
- Share price
- ₹63.18
- Market cap
- ₹884.8 Cr
- Revenue (annual)
- ₹207.2 Cr
- Net profit (annual)
- ₹26.03 Cr
- P/E (TTM)
- 30.1×Sector 19.7×
- Promoter holding
- 56.21%+0.00% QoQ
- FII holding
- 7.80%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Finkurve Financial Services Ltd
All →Finkurve Financial Services Board Meeting Date
Finkurve Financial Services will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The trading window remains closed as previously intimated.
Finkurve Financial Services Other Announcement
Finkurve clarifies that its NCD interest payment notice (Ann Id 14641482) was wrongly filed as a Regulation 50(1) board meeting intimation. It asks the exchange to disregard that entry.
Finkurve Financial Services Debt & Borrowing: ₹0.21 Cr
Finkurve paid monthly NCD interest of ₹0.21 Crore (net TDS) on ISIN INE734I07099. The payment was made on October 23, 2026, ahead of the due date.
- Value
- ₹0.21 Cr
Finkurve Financial Services Debt & Borrowing: ₹0.51 Cr
Finkurve Financial Services paid Rs. 0.51 Crore as interest on its NCDs (ISIN: INE734I07073) on October 12, 2026.
- Value
- ₹0.51 Cr
Finkurve Financial Services Other Announcement
Finkurve Financial Services Limited has submitted its Reconciliation of Share Capital Audit Report for the quarter and half-year ended September 30, 2026, pursuant to SEBI regulations.
Finkurve Financial Services Debt & Borrowing: ₹0.29 Cr
Finkurve Financial Services paid Rs. 0.0029 Crore in interest on NCDs (ISIN: INE734I07065) due on October 07, 2026, ahead of schedule.
- Value
- ₹0.29 Cr
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.